RPI-GLYT2-82 |
RPI-GLYT2-82 : Non-Competitive/Reversible of SLC6A5
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SLC6A5 |
|
up to 5 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
off-target Activity (at 10 μM):
DAT -22%,
Na channel (site 2) -16%,
SERT -88%,
NET -1.3%,
5-HT2A -7 ...
Potency Cellular
In Vitro
SLC6A5
Mode of Action: Non-Competitive/Reversible
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c03329
In Vivo Validations
Mouse
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
1.49 h
Systemic clearance:
3844 mL/min/Kg
Area Under the Curve::
508.6 h·ng/mL
Volume of Distribution at Steady-State:
7120 mL/Kg
DOI Reference: 10.1021/acs.jmedchem.5c03329
Dose: 50 mg/Kg
Route of delivery:
Oral
Plasma half life:
0.85 h
Systemic clearance:
3582.8 h·ng/mL
Cmax:
2701.6 ng/mL
Tmax:
0.5 h
Bioavailability:
27.6%
DOI Reference: 10.1021/acs.jmedchem.5c03329
Dose: 30 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
1.08 ± 0.05 h
Systemic clearance:
2063.72 ± 313.68 mL/min/Kg
Cmax:
152 ± 31 ng/mL
Tmax:
1.0 ± 0 h
Area Under the Curve::
241 ± 40 h*ng/mL
Volume of Distribution at Steady-State:
192.93 ± 23.32 L/Kg
DOI Reference: 10.1038/s41467-026-69616-5
Chemical Information
| Molecular Formula | C24H29N3O3 |
| SMILEs | CN(C)C1(CNC(=O)c2ccc3c(c2)CCN3C(=O)c2ccccc2)CCOCC1 |
| InChI | InChI=1S/C24H29N3O3/c1-26(2)24(11-14-30-15-12-24)17-25-22(28)20-8-9-21-19(16-20)10-13-27(21)23(29)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,25,28) |
| Molecular weight | 407.22 Da |
| AlogP | 2.7301 |
| HBond acceptors | 6 |
| HBond donors | 1 |
| Atoms | 59 |